CDTX Stock Analysis: Buy, Sell, or Hold?
CDTX - Cidara Therapeutics, Inc.
$221.38
0.06 (0.03%)
▲
5d:
+0.44%
30d:
+0.35%
90d:
+129.53%
BUY
MODERATE Confidence
Analysis Updated: Jan 6, 2026 12:00 AM ET
Get Alerted When CDTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CDTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CDTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CDTX is currently trading at $221.38, which is considered fair based on recent price action.
Technical Outlook: Technically, CDTX is in a strong uptrend. The price is currently testing key support at $220.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CDTX is in a strong uptrend. The price is currently testing key support at $220.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
57/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
Protect Your Profits
CDTX is technically overbought (RSI 85). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- NEUTRAL: Near Wall St target ($221.50)
Support & Resistance Levels
Support Level
$220.40
Resistance Level
$221.42
Current Trend
Strong Uptrend
Technical data as of
Jan 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-35.19
Wall Street Target
$221.50
(+0.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: April 29, 2026 6:07 AM ET
Data refreshes hourly during market hours. Next update: 7:07 AM
Data refreshes hourly during market hours. Next update: 7:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CDTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$224 | 64 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$27 | 57 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$131 | 55 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 53 HOLD |
Advanced CDTX Option Strategies
Professional options setups generated by AI based on today's CDTX price and gamma walls.
